These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
Third Harmonic Bio plans a Phase 2 trial for THB335 in chronic spontaneous urticaria and will reduce its workforce by 50% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback